Document

15-12G 1 a2022-07x21form15.htm 15-12G Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 000-33001


NATUS MEDICAL INCORPORATED
(Exact name of registrant as specified in its charter)


3150 Pleasant View Road Middleton, WI 53562 (608) 829-8500
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)


Common Stock, $0.001 par value
(Title of each class of securities covered by this Form)


None
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:



Rule 12g-4(a)(1)						☒
Rule 12g-4(a)(2)						☐
Rule 12h-3(b)(1)(i)						☒
Rule 12h-3(b)(1)(ii)						☐
Rule 15d-6						☐
Rule 15d-22(b)						☐

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, Natus Medical Incorporated has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.


	NATUS MEDICAL INCORPORATED
Date: August 1, 2022	By:	/s/ B. Drew Davies
		Name: B. Drew Davies
		Title: Executive Vice President and Chief Financial Officer

SEC Form 15-12G filed by Natus Medical Incorporated